Have your own idea? Try our Stock Screener
Canadian (TSX) Drug Retail Industry Analysis
UpdatedMar 25, 2026
DataAggregated Company Financials
Companies3
- 7D3.8%
- 3M0.3%
- 1Y23.1%
- YTDn/a
In the last week, Drug Retail has been flat. The past year has been better, since the industry has gained 19% in that time. Looking forward, earnings are forecast to decline by 51% per year.
Industry Valuation and Performance
Has the Canadian Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 25 Mar 2026 | CA$351.6m | CA$421.3m | CA$27.1m | 55.9x | 13x | 0.8x |
| Fri, 20 Feb 2026 | CA$358.6m | CA$417.4m | CA$1.1m | 369.7x | 323.4x | 0.9x |
| Sun, 18 Jan 2026 | CA$362.3m | CA$417.4m | CA$1.1m | 404.9x | 326.7x | 0.9x |
| Tue, 16 Dec 2025 | CA$347.7m | CA$417.4m | CA$1.1m | 369.7x | 313.5x | 0.8x |
| Thu, 13 Nov 2025 | CA$316.3m | CA$411.3m | CA$515.8k | 1202.6x | 613.4x | 0.8x |
| Sat, 11 Oct 2025 | CA$328.9m | CA$410.9m | -CA$1,394,243.00 | 59.2x | -235.9x | 0.8x |
| Mon, 08 Sep 2025 | CA$288.3m | CA$410.9m | -CA$1,394,243.00 | 57.5x | -206.8x | 0.7x |
| Wed, 06 Aug 2025 | CA$269.1m | CA$404.5m | -CA$1,779,599.00 | 62.1x | -151.2x | 0.7x |
| Fri, 04 Jul 2025 | CA$273.1m | CA$405.0m | -CA$3,719,599.00 | 54.7x | -73.4x | 0.7x |
| Sun, 01 Jun 2025 | CA$257.9m | CA$405.0m | -CA$3,719,599.00 | 55.3x | -69.3x | 0.6x |
| Tue, 29 Apr 2025 | CA$229.8m | CA$372.5m | -CA$5,513,825.00 | n/a | -41.7x | 0.6x |
| Thu, 27 Mar 2025 | CA$231.7m | CA$368.1m | -CA$6,489,338.00 | n/a | -35.7x | 0.6x |
| Sat, 22 Feb 2025 | CA$234.2m | CA$367.0m | -CA$7,944,338.00 | n/a | -29.5x | 0.6x |
| Mon, 20 Jan 2025 | CA$193.6m | CA$367.0m | -CA$7,944,338.00 | n/a | -24.4x | 0.5x |
| Wed, 18 Dec 2024 | CA$187.3m | CA$367.0m | -CA$7,944,338.00 | n/a | -23.6x | 0.5x |
| Fri, 15 Nov 2024 | CA$187.9m | CA$365.9m | -CA$7,071,267.00 | n/a | -26.6x | 0.5x |
| Sun, 13 Oct 2024 | CA$217.5m | CA$366.8m | -CA$8,148,267.00 | n/a | -26.7x | 0.6x |
| Tue, 10 Sep 2024 | CA$187.7m | CA$366.8m | -CA$8,148,267.00 | n/a | -23x | 0.5x |
| Thu, 08 Aug 2024 | CA$176.3m | CA$369.1m | -CA$4,361,633.00 | n/a | -40.4x | 0.5x |
| Sat, 06 Jul 2024 | CA$129.3m | CA$369.1m | -CA$3,773,000.00 | n/a | -34.3x | 0.4x |
| Mon, 03 Jun 2024 | CA$130.0m | CA$369.1m | -CA$3,773,000.00 | n/a | -34.4x | 0.4x |
| Wed, 01 May 2024 | CA$141.8m | CA$370.7m | -CA$5,405,000.00 | n/a | -26.2x | 0.4x |
| Fri, 29 Mar 2024 | CA$116.7m | CA$370.7m | -CA$5,405,000.00 | n/a | -21.6x | 0.3x |
| Sun, 25 Feb 2024 | CA$914.4m | CA$1.2b | -CA$39,086,000.00 | n/a | -23.4x | 0.7x |
| Tue, 23 Jan 2024 | CA$920.0m | CA$1.2b | -CA$43,234,000.00 | n/a | -21.3x | 0.7x |
| Thu, 21 Dec 2023 | CA$776.3m | CA$1.2b | -CA$32,998,000.00 | n/a | -23.5x | 0.6x |
| Sat, 18 Nov 2023 | CA$889.0m | CA$1.2b | -CA$32,998,000.00 | n/a | -26.9x | 0.7x |
| Mon, 16 Oct 2023 | CA$921.7m | CA$1.2b | -CA$33,343,000.00 | n/a | -27.6x | 0.8x |
| Wed, 13 Sep 2023 | CA$781.8m | CA$1.2b | -CA$33,343,000.00 | n/a | -23.4x | 0.6x |
| Fri, 11 Aug 2023 | CA$940.2m | CA$1.2b | -CA$33,343,000.00 | n/a | -28.2x | 0.8x |
| Sun, 09 Jul 2023 | CA$833.9m | CA$1.1b | -CA$49,239,000.00 | n/a | -16.9x | 0.7x |
| Tue, 06 Jun 2023 | CA$977.8m | CA$1.1b | -CA$40,586,633.00 | n/a | -24.1x | 0.9x |
| Thu, 04 May 2023 | CA$1.0b | CA$1.1b | -CA$41,199,633.00 | n/a | -25.5x | 1x |
| Sat, 01 Apr 2023 | CA$1.1b | CA$1.1b | -CA$70,486,307.00 | n/a | -16.2x | 1x |
Price to Earnings Ratio
-16.2x
Current Industry PE
- There are only 3 companies in the Canadian Drug Retail industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- Total earnings for the Drug Retail industry have gone up over the last three years and the industry is now profitable.
- Revenues have declined 27% per year.
- This means that less sales are being generated overall, but since the cost of doing business is lower, profits have been increasing.
Industry Comparison
How does Canadian Drug Retail compare with similar industries?
| CA Market | -2.66% | |
| Consumer Staples | -2.98% | |
| Food and Staples Retail | -3.22% | |
| Drug Retail | 3.81% | |
| Food Retail | -3.23% | |
| Big Box Super Stores | -4.55% | |
| Food Distributors | -8.81% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CRRX CareRx | CA$3.87 | 4.3% +CA$10.0m | 40.7% | PE9.3x | |
| PCRX PharmaCorp Rx | CA$0.45 | 4.7% +CA$3.3m | -13.5% | PE396.1x |